ENPP1 and cancer: To evaluate the novel Enpp1 inhibitor as a cancer therapy, C67BL/6 mice were implanted with MC38 tumors and once established, mice were randomized to receive daily oral gavage of the VIR3 Enpp1 inhibitor.